Related Experiment Video
Updated: Dec 1, 2025

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
CASK, APBA1, and STXBP1 collaborate during insulin secretion
Kai Zhang1, Tianyuan Wang1, Xingjing Liu1
1Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Medical School, Southeast University, Nanjing, 210009, China.
Abstract:
Calcium/calmodulin-dependent serine protein kinase (CASK) knockdown reduces insulin vesicle docking to cell membranes. Here, we explored CASK interactions with other proteins during insulin secretion. Using co-immunoprecipitation, liquid chromatography-mass spectrometry and bioinformatic analysis, we identified that CASK, Adapter protein X11 alpha (APBA1), and Syntaxin binding protein 1 (STXBP1) formed tripartite complex during insulin secretion. CASK enhanced APBA1-STXBP1 interaction and mediated their traffic from cytoplasm to plasma membrane during insulin release. High fatty acid stimulation decreased insulin secretion along with CASK, APBA1, and STXBP1 expression; Cask overexpression enhanced CASK/APBA1/STXBP1 tripartite complex function, and may thereby rescue lipotoxicity-induced insulin-release defects. Collectively, our results illustrated the function of CASK in insulin granules exocytosis, which broadens the underlying mechanism of insulin secretion and highlights the clinical potential of CASK as a drug target of type 2 Diabetes Mellitus (T2DM).
Insights
Calcium/calmodulin-dependent serine protein kinase (CASK) is crucial for insulin secretion. This study reveals CASK forms a complex with APBA1 and STXBP1, essential for releasing insulin and potentially treating type 2 diabetes.
Area of Science:
- Cell Biology
- Endocrinology
- Molecular Biology
Background:
- Insulin secretion is vital for glucose homeostasis.
- Calcium/calmodulin-dependent serine protein kinase (CASK) is implicated in insulin vesicle trafficking.
- Understanding CASK's role in insulin secretion is crucial for metabolic disease research.
Purpose of the Study:
- To elucidate the molecular interactions of CASK during insulin secretion.
- To investigate the tripartite complex involving CASK, APBA1, and STXBP1.
- To explore the therapeutic potential of CASK in type 2 diabetes.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Liquid chromatography-mass spectrometry for protein identification.
- Bioinformatic analysis to understand complex formation and function.
Main Results:
- CASK, APBA1, and STXBP1 form a tripartite complex during insulin secretion.
- CASK enhances APBA1-STXBP1 interaction and mediates their transport to the plasma membrane.
- High fatty acid levels impair insulin secretion by reducing CASK, APBA1, and STXBP1 expression.
- CASK overexpression can rescue lipotoxicity-induced insulin release defects.
Conclusions:
- CASK plays a critical role in insulin granule exocytosis.
- The CASK/APBA1/STXBP1 complex is a key regulator of insulin secretion.
- CASK represents a potential therapeutic target for type 2 diabetes mellitus.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cell Specific Gene Expression
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Insulin: The Receptor and Signaling Pathways

